Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Budesonide (PT027 vs Pulmicort) in Children with Asthma
NCT04848662Phase 1Completed
- Sponsor
- Bond Avillion 2 Development LP
- Start
- May 2021
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of salbutamol + budesonide in asthma (2 arms), sponsored by Bond Avillion 2 Development LP. Primary endpoints: Area Under the Curve from time 0 to the last measurable concentration and Maximum Plasma Concentration. Started May 2021; status: completed.
02
Drugs
salbutamol + budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04848662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04848662.